A Multi-Centre, Web-Accessible and Quality Control-Checked Database of in vivo MR Spectra of Brain Tumour Patients

Rohringer M, Sutherland GR, Louw DF, Sima AA (1989) Incidence and clinicopathological features of meningioma. J Neurosurg 71(5 Pt 1):665–72

Kleihues P, Cavenee WK editors (2000) Pathology and genetics of tumours of the nervous system (World Health Organization Classification of Tumours) 2nd edn. IARC Press, Lyon

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89(4):547–51

Danielsen ER, Ross B (1999) Magnetic resonance spectroscopy diagnosis of neurological diseases. Marcel Dekker, New York

Alger JR, Frew AJ, Cloughesy TF, del Vecchio W, Villablanca JP, Curran JG (2002) Novel methodology for the archiving and interactive reading of clinical magnetic resonance spectroscopic imaging. Magn Reson Med 48:411–418

INTERPRET project: http://azizu.uab.es/INTERPRET

validated-DB: http://azizu.uab.es/INTERPRET/int_Disc_FrozenDB.shtml

Magnetic resonance spectroscopy protocols: http://azizu.uab.es/INTERPRET/mrs_data/mrs_data.html

Tate AR, Majos C, Moreno A, Howe FA, Griffiths JR, Arus C (2003) Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study. Magn Reson Med 49 (1): 29–36

Clinical data protocols: http://azizu.uab.es/INTERPRET/clinical_data/clinical_data.html

Candiota AP, Majos C, Bassols A, Cabanas ME, Acebes JJ, Quintero MR, Arus C (2004) Assignment of the 2.03 ppm resonance in in vivo 1H MRS of human brain tumour cystic fluid: contribution of macromolecules. MAGMA, Magn Reson Mater Phy 17 (1): 36–46

Quality Control of MR spectra: http://azizu.uab.es/INTERPRET/mrs_data/docs/MRS_QC.pdf

List of signed diagnoses: http://azizu.uab.es/INTERPRET/private/technical_reports.shtml Document number: 164

Lefournier V, Underwood J, Bosson J, Julià-Sapé M, Van Der Graaf M, Howe F, Majós C, Moreno A, Rémy C, Arús C (2004) The added value of single-voxel proton magnetic resonance. MAGMA, Magn Reson Mater Phy 17(1):49

Murphy M, Loosemore A, Ferrer I, Wesseling P, Wilkins PR, Bell BA (2002) Neuropathological diagnostic accuracy. Br J Neurosurg 16(5):461–464

Tate AR, Griffiths JR, Martinez-Perez I, Moreno A, Barba I, Cabanas ME, Watson D, Alonso J, Bartumeus F, Isamat F, Ferrer I, Vila F, Ferrer E, Capdevila A, Arus C (1998) Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed 11(4,5):177–191

European Parliament and Council. Directive 95/46/EC (1995) Official Journal 281:0031–0050 http://europa.eu.int/comm/internal_market/privacy/law_en.htm#directive

Juan Carlos I. Ley Orgánica 15/1999 de Protección de Datos (1999) Boletín Oficial del Estado (BOE), 298:43088–43099 http://www.boe.es/boe/dias/1999-12-14/pdfs/A43088-43099.pdf

Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol (Berl) 109(1):93–108

Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19:579–592

Osborn AG (eds). (1994) Diagnostic neuroradiology Mo. Mosby, St Louis

eTUMOUR project: http://biospin.uv.es or http://www.etumour.net

Remmelinck M, Lopes MB, Nagy N, Rorive S, Rombaut K, Decaestecker C, Kiss R, Salmon I (2000) How could static telepathology improve diagnosis in neuropathology?. Anal Cell Pathol 21(3,4):177–82

Acosta DM, van der Graaf M, Julià-Sapé M, Rijpkema M, Moreno A, Majós C, Howe F, Arús C, Watson D (2002) An automated empirical approach for quality control filtering of single voxel 1H spectra for brain tumour classification. MAGMA, Magn Reson Mater Phy 15(1):140–141

Kreis R (2004) Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 17(6):361–81